ArthralgiaNitrilesTriazolesAromatase InhibitorsAntineoplastic Agents, HormonalPostmenopauseTamoxifenAlphavirus InfectionsBreast NeoplasmsChikungunya virusReunionEstrogen AntagonistsNeoplasms, Hormone-DependentEstrogen Receptor ModulatorsTreatment OutcomeChemotherapy, AdjuvantReceptors, EstrogenEstradiolAromataseDouble-Blind MethodAndrostadienesJoint DiseasesGoserelinEstroneSapogeninsDisease-Free SurvivalEstrogensMegestrolTenosynovitisSelective Estrogen Receptor ModulatorsNeoadjuvant TherapyMegestrol AcetateAntineoplastic Combined Chemotherapy ProtocolsDrug IncompatibilityCryoglobulinemiaVirginiamycinWhipple DiseaseArthritisStill's Disease, Adult-OnsetSkin Diseases, VascularReceptors, ProgesteroneMuscular DiseasesDyssomniasKi-67 AntigenAntineoplastic AgentsEtidronic AcidAlphavirusProspective StudiesDrug Administration ScheduleVasculitis, Leukocytoclastic, CutaneousCytochrome P-450 CYP2D6Prodromal SymptomsEnzyme InhibitorsEjaculatory DuctsArthritis, InfectiousPurpura, Schoenlein-HenochTropherymaTemporomandibular Joint Dysfunction SyndromeCryopyrin-Associated Periodic SyndromesAndrostenedioneErythema InfectiosumDilatation and CurettageScabiesBrucellosisFeverRheumatoid FactorFacial PainExanthemaFamilial Mediterranean FeverTestosteroneCross-Over StudiesArthritis, ReactiveParvovirus B19, HumanRetrospective StudiesFollow-Up StudiesPaclitaxelTemporomandibular Joint DisordersSurvival RatePremenopauseClinical Trials as TopicMyositisDrug Therapy, CombinationUterine HemorrhageImmunoglobulin MNeoplasm MetastasisAustriaRecurrenceTravelDisease OutbreaksPainChondrocalcinosisNeoplasm Recurrence, LocalSurvival AnalysisGlucuronosyltransferaseUrticariaHysteroscopyBone Density Conservation AgentsSynovitisDose-Response Relationship, DrugMusculoskeletal Diseases